In 1984 we reported on a patient who presented an immune thrombocytopenic purpura with hypermega-karyocytosis under amitriptyline treatment [Acta haemat. 72: 355-356, 1984]. Subsequently, the patient developed a pure megakaryocytic aplasia (PMA) during the course of chronic hepatitis B. The pathogen-etic implications were discussed. In January 1985 the patient interrupted stanazolol and prednisone therapy because this therapy had no effect on the peripheral blood and bone marrow picture; the platelet counts ranged between 20 and 42 × 10Vl; serum HB < ‚Ag test remained positive; other data were in the normal range. Spontaneously, in November 1987, the patient had a progressive increase in the number of megakaryo-cytes, that previously were almost absent and presently most of them appear in clusters of 7-8 cells. HBsAg test became negative and HBS antibodies showed a progressive increase; liver biopsy revealed only a modest fibrosis. Posthepatitic aplastic anemia is generally caused by non-A, non-B hepatitis, whereas hepatitis B had been rarely reported as a cause of aplastic anemia and never, as far as we know, of PMA; furthermore, these forms are particularly severe. The unusual course of this case could strongly suggest an etiological role of B-virus in the induction of PMA possibly via a direct action on megakaryocytes.
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